|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 0173-0681 | RELENZA | zanamivir | GlaxoSmithKline LLC | POWDER | 1999-09-22 | |
| 72769-181 | Rapivab | peramivir | BioCryst Pharmaceuticals, Inc. | SOLUTION | 2014-12-20 |
Loading full table content...